Hemcalm

Horse Chestnut, Collinsonia Canadensis Root, Hamamelis Virginiana Root Bark/stem Bark


Boiron
Human Otc Drug
NDC 0220-9178
Hemcalm also known as Horse Chestnut, Collinsonia Canadensis Root, Hamamelis Virginiana Root Bark/stem Bark is a human otc drug labeled by 'Boiron'. National Drug Code (NDC) number for Hemcalm is 0220-9178. This drug is available in dosage form of Ointment. The names of the active, medicinal ingredients in Hemcalm drug includes Collinsonia Canadensis Root - 1 [hp_X]/1 Hamamelis Virginiana Root Bark/stem Bark - 1 [hp_X]/1 Horse Chestnut - 1 [hp_X]/1 . The currest status of Hemcalm drug is Active.

Drug Information:

Drug NDC: 0220-9178
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Hemcalm
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Horse Chestnut, Collinsonia Canadensis Root, Hamamelis Virginiana Root Bark/stem Bark
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Boiron
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Ointment
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:COLLINSONIA CANADENSIS ROOT - 1 [hp_X]/1
HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK - 1 [hp_X]/1
HORSE CHESTNUT - 1 [hp_X]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Jan, 2020
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 07 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:BOIRON
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:O2630F3XDR
T7S323PKJS
3C18L6RJAZ
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
0220-9178-5130 OINTMENT in 1 TUBE (0220-9178-51)01 Jan, 2020N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Aesculus hippocastanum 1x hpus 1.3% reduces swelling and relieves stinging pain associated with external hemorrhoids* collinsonia canadensis 1x hpus 1.3% relieves hemorroids associated with constipation* hamamelis virginiana 1x hpus 1.3% relieves burning, itching and discomfort associated with hemorrhoids*

Product Elements:

Hemcalm horse chestnut, collinsonia canadensis root, hamamelis virginiana root bark/stem bark hamamelis virginiana root bark/stem bark hamamelis virginiana root bark/stem bark petrolatum collinsonia canadensis root collinsonia canadensis root alcohol horse chestnut horse chestnut

Indications and Usage:

Temporarily relieves symptoms of hemorrhoids such as: burning, itching, swelling, pain, discomfort. helps shrink swollen hemorriods. relieves hemorrhoid symptoms following childbirth.

Warnings:

For external use only. do not put this product into the rectum by using fingers or any mechanical device or applicator. when using this product, do not exceed the recommended daily dosage unless directed by a doctor.

Dosage and Administration:

Adults and children 12 years of age and older: when practical, gently cleanse the affected area with mild soap and warm water and rinse throughly. gently dry by patting or blotting with toilet tissue or a soft cloth before applicaiton of product. apply hemcalm ointment externally to the affected area up to 4 times a day. children under 12 years of age: ask a doctor.

Stop Use:

Stop use and ask a doctor if symptoms persist for more than 7 days or worsen.

Package Label Principal Display Panel:

Label label label

Further Questions:

1-800-boiron-1 (1-800-264-7661), boironusa.com info@boiron.com distributed by boiron, inc. newtown square, pa 19073


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.